The scope of false, exaggerated and medical efficacy claims used for cosmetics in Taiwan is clarified.
On Jan. 10 and Jan. 19, 2019, TFDA released 2 cosmetic regulation drafts, “Particulars of Specific Purpose Cosmetics that May Be Voluntarily Modified” and “Regulations Governing of Criteria for the Label, Promotion and Advertisement of Cosmetic Products Identify False, Exaggerated or Medical Efficacy”. Cosmetic stakeholders with any suggestions or comments can send to us (cosmetic@chemlinked.com) before Mar 5, 2019. We will sort your suggestion, submit them to TFDA and send back the reply to you.
Cosmetic Hygiene Safety Administration Act released on May 2, 2018, stipulated that the labels, claims and advertisements of cosmetics shall not be false, exaggerated or indicate medical efficacy. The draft clarifies the scope of false, exaggerated or medical efficacy claims, as well as acceptable claims/labels/advertisements.
Dear Readers, The Skinobs team would like to apologise sincerely to Faiza Hussain, Co-Founder and…
Acheless is an essential wearable device for modern society, where digital living is commonplace. To…
Linking consumer data with sensory data is an essential step in formulating products that accurately…